Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

142.84USD
18 Sep 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$142.84
Open
--
Day's High
--
Day's Low
--
Volume
70
Avg. Vol
3,761,210
52-wk High
$142.89
52-wk Low
$96.93

Mario, Ernest 

Dr. Ernest Mario, Ph.D., serves as Independent Director of Celgene Corp. Dr. Mario is a former Deputy Chairman and Chief Executive of Glaxo Holdings plc and a former Chairman and Chief Executive Officer of ALZA Corporation. He also serves as Chairman of Capnia, Inc. and Chimerix, Inc., and as a Director of Tonix Pharmaceuticals Holding Corp. (member of the Compensation Committee). Dr. Mario previously served as a Director of Boston Scientific Corporation, Kindred Biosciences Inc., Maxygen Inc., VIVUS Inc. and XenoPort Inc. In 2007, Dr. Mario was awarded the Remington Medal by the American Pharmacists Association, pharmacy’s highest honor. Dr. Mario earned a B.S. in Pharmacy from Rutgers University and a M.S. and a Ph.D. in Physical Sciences from the University of Rhode Island. Dr. Mario brings to his service as a director his significant executive leadership experience, including his experience leading several pharmaceutical companies, as well as his membership on public company boards and foundations. He also has extensive experience in financial and operations management, risk oversight, and quality and business strategy.

Basic Compensation

Total Annual Compensation, USD 93,750
Restricted Stock Awards, USD 112,478
Long-Term Incentive Plans, USD --
All Other, USD 337,393
Fiscal Year Total, USD 543,621

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Robert Hugin

16,526,200

Scott Smith

6,463,800

Mark Alles

12,192,400

Peter Kellogg

8,137,270

Terrie Curran

--

Michael Pehl

--
As Of  30 Dec 2016